Prognostic biomarkers and molecular targets provide treatment options for patients with metastatic/advanced melanoma; however, acquired resistance to some drugs still proves challenging.
Advanced, metastatic melanoma is an aggressive disease with a poor prognosis; but therapies targeting gene mutations may offer hope to some patients.
This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.
This patient fact sheet describes risk factors and preventative measures in skin cancer, malignant melanoma.
This fact sheet helps cancer patients learn what they can do to protect themselves from skin cancer.
Review slide-by-slide drug information for SYLATRON® (peginterferon alfa-2b) for treatment of melanoma.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 8: ...
Melanoma is the most dangerous type of skin cancer, and the most deadly. It begins in the melanocytes, but may ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|